PTC Therapeutics may reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the ...
PTC Therapeutics (PTCT) announced that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150M ...
Space on MSN6d
Mass Effect: The Board Game — Priority: Hagalaz reviewIt's been 17 long years since we last cruised around the galaxy aboard the SSV Normandy, but we're finally back thanks to ...
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License ...
US FDA accepts for review GSK’s Blenrep combinations for the treatment of relapsed/refractory multiple myeloma: London, UK Tuesday, November 26, 2024, 09:00 Hrs [IST] GSK plc an ...
The Centre on Monday asked all states to review and update fire prevention and response plans of all health facilities, including training of healthcare staff on safety protocols and ensuring regular ...
PTC Therapeutics ( (PTCT) ) just unveiled an update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback